News
-
-
-
-
PRESS RELEASE
Kedrion: at ESID 2026, experts call for earlier diagnosis and greater awareness as Secondary Immunodeficiencies continue to rise
Experts at ESID 2026 emphasize the need for earlier diagnosis and increased awareness of Secondary Immunodeficiencies, highlighting challenges and calls for improved patient outcomes -
-
-
PRESS RELEASE
seragy Launches with €12 Million Financing to Advance Quantitative Biomarkers for Neurodegenerative Diseases
seragy holding GmbH secures €12 million financing to advance quantitative biomarkers for neurodegenerative diseases through its SeRAS® technology, backed by Commerzbank, MBG, and the State of Lower Saxony -
PRESS RELEASE
KNDS PRESENTS ITS INNOVATIONS FOR INFANTRY COMBAT AT THE 2026 NATIONAL INFANTRY DAYS
KNDS presents its innovations for infantry combat at the 2026 National Infantry Days, showcasing cutting-edge technologies for modernizing land forces through tactical connectivity, robotics, and drone-based systems -
PRESS RELEASE
KNDS PRESENTE SES INNOVATIONS POUR LE COMBAT D'INFANTERIE AUX JOURNEES NATIONALES DE L’INFANTERIE 2026
KNDS présente ses innovations technologiques et robotiques lors des Journées Nationales de l'Infanterie 2026, avec focus sur connectivité tactique et drone, PHORIO pour communications radio sécurisées, gamme robotique modulaire NERVA, et solutions pour forces terrestres -
PRESS RELEASE
EQS-Adhoc: GRAMMER AG: Difference in earnings performance in the third quarter of 2026 compared to the previous year and update to the earnings forecast for full-year 2026
GRAMMER AG reports lower earnings in Q3 2026 with update to full-year forecast. Impact of Iran conflict and special tariffs explained